These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6354520)

  • 1. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
    Takemura J; Seino Y; Yamamura T; Yoshiya K; Ishikawa Y; Itoh N; Imura H
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis.
    Takemura J; Seino Y; Yamamura T; Tsuda K; Seino S; Itoh N; Imura H
    J Clin Endocrinol Metab; 1982 May; 54(5):909-13. PubMed ID: 7037822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
    Lauritsen KB; Moody AJ
    Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
    Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
    J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy.
    Lauritsen KB; Moesgaard F; Nielsen ML; Jensen SL
    Scand J Gastroenterol; 1982 Jun; 17(4):507-11. PubMed ID: 6753107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
    Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
    Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
    Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.
    Lauritsen KB; Frederiksen HJ; Uhrenholdt A; Holst JJ
    Scand J Gastroenterol; 1982 Jun; 17(4):513-6. PubMed ID: 6753108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of gastric inhibitory polypeptide in normal and duodenal ulcer patients.
    Cataland S; O'Dorisio TM; Brooks R; Mekhjian HS
    Gastroenterology; 1977 Jul; 73(1):19-22. PubMed ID: 863190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
    Jorde R; Schulz TB; Burhol PG; Schulz LB
    Regul Pept; 1981 Nov; 2(6):391-9. PubMed ID: 7029674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of selective proximal vagotomy on gastrin, GIP and insulin blood levels in patients with duodenal ulcer].
    Börger HW; Schafmayer A; Becker HD
    Chir Forum Exp Klin Forsch; 1978; (1978):25-9. PubMed ID: 752595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastric inhibitory polypeptide (GIP) (author's transl].
    Ebert R; Finke U
    Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
    Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies with gastric inhibitory polypeptide.
    Brown JC; Otte S
    World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric inhibitory polypeptide.
    Ebert R; Creutzfeldt W
    Clin Gastroenterol; 1980 Sep; 9(3):679-98. PubMed ID: 6107191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of vagotomy upon GIP release in patients with peptic ulcer.
    Imamura M; Kameyama J; Naito H; Sato T; Ohneda A
    Tohoku J Exp Med; 1984 Jul; 143(3):335-44. PubMed ID: 6385345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y; Furukawa Y; Sato T; Yumita S; Bloom SR
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):98-109. PubMed ID: 7044844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.